Debt to Equity Ratio Chart

View Debt to Equity Ratio for VVTM.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2005. Start Trial.
Date Value
March 31, 2026 -0.4645
December 31, 2025 -0.5802
September 30, 2025 -1.971
June 30, 2025 -0.4862
March 31, 2025 -0.7199
December 31, 2024 -0.7175
September 30, 2024 -0.7096
June 30, 2024 -0.7379
March 31, 2024 -0.7049
December 31, 2023 -0.7315
September 30, 2023 -0.7317
June 30, 2023 -0.7482
March 31, 2023 -0.7453
December 31, 2022 -0.7762
September 30, 2022 -0.762
June 30, 2022 -0.7969
March 31, 2022 -0.7817
December 31, 2021 -0.7717
September 30, 2021 -0.7653
June 30, 2021 -0.8491
March 31, 2021 -0.9494
December 31, 2020 -0.9566
September 30, 2020 -0.8666
June 30, 2020 -0.8145
March 31, 2020 -0.3492
Date Value
December 31, 2019 -0.4236
September 30, 2019 -0.5991
June 30, 2019 -0.7084
March 31, 2019 -0.8257
December 31, 2018 -0.67
September 30, 2018 -17.05
June 30, 2018 8.438
March 31, 2018 3.461
December 31, 2017 5.425
September 30, 2017 6.203
June 30, 2017 7.342
March 31, 2017 -93.39
December 31, 2016 8.810
September 30, 2016 3.762
June 30, 2016 3.29
March 31, 2016 3.336
December 31, 2015 1.992
September 30, 2015 1.19
June 30, 2015 1.120
March 31, 2015 0.675
December 31, 2014 0.4728
September 30, 2014 0.5111
June 30, 2014 0.6482
March 31, 2014 1.497
December 31, 2013 1.311

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
MedMira, Inc. -0.7106
MedX Health Corp. -0.8123
VentriPoint Diagnostics Ltd. -0.632
Theralase Technologies, Inc. 0.2214
Profound Medical Corp. 0.1482